113 related articles for article (PubMed ID: 24135337)
1. Pharmacological characteristics of zolpidem-induced catalepsy in the rat.
Mierzejewski P; Kolaczkowski M; Nowak N; Korkosz A; Scinska A; Sienkiewicz-Jarosz H; Samochowiec J; Kostowski W; Bienkowski P
Neurosci Lett; 2013 Nov; 556():99-103. PubMed ID: 24135337
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-like effects of zolpidem in Wistar rats.
Mierzejewski P; Kolaczkowski M; Marcinkowska M; Wesolowska A; Samochowiec J; Pawlowski M; Bienkowski P
Eur J Pharmacol; 2016 Feb; 773():51-8. PubMed ID: 26825544
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
[TBL] [Abstract][Full Text] [Related]
4. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
Verma A; Kulkarni SK
Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Banasikowski TJ; Beninger RJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):761-8. PubMed ID: 22410316
[TBL] [Abstract][Full Text] [Related]
6. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
[TBL] [Abstract][Full Text] [Related]
7. The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization.
Riedinger K; Kulak A; Schmidt WJ; von Ameln-Mayerhofer A
Behav Brain Res; 2011 Mar; 218(1):194-9. PubMed ID: 21130808
[TBL] [Abstract][Full Text] [Related]
8. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
9. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.
Chartoff EH; Ward RP; Dorsa DM
J Pharmacol Exp Ther; 1999 Nov; 291(2):531-7. PubMed ID: 10525068
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
Moore NA; Blackman A; Awere S; Leander JD
Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents.
Sotoing Taïwe G; Ngo Bum E; Talla E; Dawe A; Okomolo Moto FC; Temkou Ngoupaye G; Sidiki N; Dabole B; Djomeni Dzeufiet PD; Dimo T; De Waard M
J Ethnopharmacol; 2012 Aug; 143(1):213-20. PubMed ID: 22750453
[TBL] [Abstract][Full Text] [Related]
12. Bidirectional effects of benzodiazepine binding site ligands in the passive avoidance task: differential antagonism by flumazenil and beta-CCt.
Savić MM; Obradović DI; Ugresić ND; Cook JM; Yin W; Bokonjić DR
Behav Brain Res; 2005 Mar; 158(2):293-300. PubMed ID: 15698896
[TBL] [Abstract][Full Text] [Related]
13. Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Kinoshita H; Hasegawa T; Kameyama T; Yamamoto I; Nabeshima T
Neurosci Lett; 1994 Jun; 174(1):101-4. PubMed ID: 7970141
[TBL] [Abstract][Full Text] [Related]
14. Modulation of haloperidol-induced catalepsy in rats by GABAergic neural substrate in the inferior colliculus.
Tostes JG; Medeiros P; Melo-Thomas L
Neuroscience; 2013; 255():212-8. PubMed ID: 24125891
[TBL] [Abstract][Full Text] [Related]
15. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
Sevak RJ; Koek W; France CP
Eur J Pharmacol; 2005 Jul; 517(1-2):64-7. PubMed ID: 15975572
[TBL] [Abstract][Full Text] [Related]
16. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
Tzschentke TM; Schmidt WJ
Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
[TBL] [Abstract][Full Text] [Related]
17. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors.
Brudzynski SM; Komadoski M; St Pierre J
Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
Rowlett JK; Spealman RD; Lelas S
J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy.
Medeiros P; Viana MB; Barbosa-Silva RC; Tonelli LC; Melo-Thomas L
Behav Brain Res; 2014 Jul; 268():8-13. PubMed ID: 24667361
[TBL] [Abstract][Full Text] [Related]
20. Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists.
Koek W; France CP
Psychopharmacology (Berl); 2008 Aug; 199(2):191-8. PubMed ID: 18446324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
